UK's EMA Says Novo Nordisk Decided Norditropin Nordiflex Will Be Discontinued Entirely; Discontinuation Of Norditropin Nordiflex To Come Into Effect From 2024 End, Timelines May Vary From Country To Country
Portfolio Pulse from Benzinga Newsdesk
Novo Nordisk has decided to discontinue its Norditropin Nordiflex product entirely, with the discontinuation taking effect from the end of 2024. The timelines for this discontinuation may vary by country.
October 28, 2024 | 6:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Novo Nordisk will discontinue its Norditropin Nordiflex product by the end of 2024, with varying timelines across countries.
The discontinuation of Norditropin Nordiflex could impact Novo Nordisk's product portfolio and revenues, but the overall effect on the stock price is uncertain as it depends on how the company manages the transition and compensates with other products.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80